Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Cancer Peritoneal”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT02399410
What this trial is testing

Perioperative Chemotherapy With Bevacizumab for Colorectal Carcinomatosis

Who this might be right for
Colorectal Neoplasms
University Hospital, Ghent 60
Testing effectiveness (Phase 2)Active Not RecruitingNCT02834013
What this trial is testing

Nivolumab and Ipilimumab in Treating Patients With Rare Tumors

Who this might be right for
Acinar Cell CarcinomaAdenoid Cystic CarcinomaAdrenal Cortical Carcinoma+91 more
National Cancer Institute (NCI) 798
Testing effectiveness (Phase 2)Study completedNCT01379482
What this trial is testing

Neo-adjuvant Chemo + Peritonectomy + Hyperthermic Intraperitoneal Chemo in Peritoneal Carcinomatosis From Gastric Cancer

Who this might be right for
Peritoneal CarcinomatosisGastric Cancer
Uppsala University 18
Testing effectiveness (Phase 2)Ended earlyNCT05687617
What this trial is testing

Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.

Who this might be right for
Gastric CancerGastric AdenocarcinomaPeritoneal Carcinomatosis+1 more
Laval University 11
Not applicableEnded earlyNCT02441140
What this trial is testing

Detection of Tumor Associated Cell-free DNA in Peritoneal Fluid Obtained by Culdocentesis

Who this might be right for
Stage III Ovarian CancerStage IV Ovarian Cancer
Dana-Farber Cancer Institute 5
Testing effectiveness (Phase 2)Ended earlyNCT01936974
What this trial is testing

(PGA) for Platinum-resistant/Refractory, Paclitaxel-Pretreated Recurrent Ovarian and Peritoneal Carcinoma

Who this might be right for
Ovarian CarcinomaFallopian Tube CarcinomaPeritoneal Carcinoma
Western Regional Medical Center 7
Not applicableStudy completedNCT03367260
What this trial is testing

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

Who this might be right for
Ovarian CancerFallopian Tube CancerPrimary Peritoneal Carcinoma
Duke University 115
Not applicableUnknownNCT05185791
What this trial is testing

ERAS® Guidelines Validation of CRS With or Without HIPEC

Who this might be right for
Peritoneal Diseases
Hospices Civils de Lyon 288
Not applicableUnknownNCT02102074
What this trial is testing

Intra-peritoneal Environmental Changes Following Surgery

Who this might be right for
Tumor Cells and Tumor Markers in Peritoneal Cavity
Meir Medical Center 70
Testing effectiveness (Phase 2)Study completedNCT01525771
What this trial is testing

Safety Study of Combined Systemic and Intraperitoneal Chemotherapy to Treat Stomach Cancer

Who this might be right for
Stage IV Gastric Cancer With Metastasis
Asan Medical Center 37
Testing effectiveness (Phase 2)UnknownNCT02562365
What this trial is testing

Adjuvant Chemotherapy of Three-step Regimen in Ovarian Cancer

Who this might be right for
Ovarian Cancer
Xiaohua Wu MD 130
Not applicableStudy completedNCT03002909
What this trial is testing

Continuous Pre-peritoneal Wound Infiltration Versus Epidural Analgesia in Cancer Surgery

Who this might be right for
Abdominal Neoplasms
Assiut University 40
Early research (Phase 1)Study completedNCT01489371
What this trial is testing

EGEN-001 and Pegylated Liposomal Doxorubicin Hydrochloride in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Primary Peritoneal Cancer

Who this might be right for
Ovarian Clear Cell CystadenocarcinomaOvarian Endometrioid AdenocarcinomaOvarian Seromucinous Carcinoma+5 more
Gynecologic Oncology Group 16
Testing effectiveness (Phase 2)UnknownNCT03095001
What this trial is testing

Intraperitoneal Chemotherapy Alone or in Combination With Bevacizumab for Ovarian Cancer With Peritoneal Adhesion

Who this might be right for
Peritoneal Adhesion
Chinese PLA General Hospital 70
Testing effectiveness (Phase 2)Study completedNCT00216112
What this trial is testing

Imatinib Mesylate in Combination With Docetaxel for Advanced, Platinum-Refractory Ovarian Cancer

Who this might be right for
Ovarian Cancer
Daniela Matei, MD 23
Early research (Phase 1)Study completedNCT01649336
What this trial is testing

MEK162 and Paclitaxel in Patients With Epithelial Ovarian, Fallopian Tube or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
Array Biopharma, now a wholly owned subsidiary of Pfizer 36
Very early researchUnknownNCT05565014
What this trial is testing

Safety and Efficacy Study of Virus Activated Killer Immune Cells (VAK) for Malignant Pleural and Peritoneal Effusion

Who this might be right for
Malignant Pleural EffusionMalignant Peritoneal Effusion
Sheng Hu 90
Large-scale testing (Phase 3)Looking for participantsNCT07271355
What this trial is testing

Pressurized Intraperitoneal Aerosolized Chemotherapy With Mitomycin for the Treatment of Unresectable Appendix or Colorectal Cancer With Peritoneal Metastases, The IMPACT Trial

Who this might be right for
Metastatic Appendix CarcinomaMetastatic Colorectal CarcinomaMetastatic Malignant Neoplasm in the Peritoneum+3 more
City of Hope Medical Center 129
Not applicableLooking for participantsNCT07004647
What this trial is testing

MT027 Cell Injection in Patients With Advanced Primary or Secondary Peritoneal Tumors

Who this might be right for
Peritoneal Tumor
Ruijin Hospital 10
Large-scale testing (Phase 3)Looking for participantsNCT06580314
What this trial is testing

Testing Olaparib for One or Two Years, With or Without Bevacizumab, to Treat Ovarian Cancer

Who this might be right for
Fallopian Tube Endometrioid AdenocarcinomaFallopian Tube High Grade Serous AdenocarcinomaFallopian Tube Malignant Mixed Mesodermal (Mullerian) Tumor+9 more
NRG Oncology 880
Next Page